(Q43501040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

HIV-1 neutralizing antibody and approaches to the envelope diversity problem (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

HIV-1 Neutralizing Antibody and Approaches to the Envelope Diversity Problem (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

9 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1725234

9 November 2022

4

D Bolognesi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

author name string

T. J. Matthews

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1725234

9 November 2022

A. J. Langlois

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1725234

9 November 2022

S. Butto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1725234

9 November 2022

K. Javaherian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1725234

9 November 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

http://link.springer.com/content/pdf/10.1007/978-1-4684-6000-1_3.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Advances in Experimental Medicine and Biology

9 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

23-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

9 November 2022

2

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae

9 November 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Proceedings of the National Academy of Sciences of the United States of America

9 November 2022

5

85

7023

P Berman

1986

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

9 November 2022

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

9 November 2022

7

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

9 November 2022

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

9 November 2022

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

9 November 2022

15

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

9 November 2022

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

9 November 2022

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

9 November 2022

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

9 November 2022

20

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

9 November 2022

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

9 November 2022

23

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_3

9 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1725234%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference